Summit Therapeutics PLC Earnings

The next earnings date for Summit Therapeutics PLC is October 28, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Summit Therapeutics PLC Earnings

Report DateEstimated Earnings Per Share
10/28/2025$-0.10

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Summit Therapeutics PLC Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/06/2025---$0100.00%
04/29/2025Before Market$-0.070.73%
10/30/2024Before Market$-0.08-14.29%
08/06/2024Before Market$-0.09-50.00%
05/01/2024Before Market$-0.060.00%
02/20/2024---$-0.05---
11/07/2023---$-0.03---
08/09/2023---$-0.02---
05/11/2023---$-1.43---
03/09/2023---$-0.09---
11/09/2022---$-0.14---
08/11/2022---$-0.17---
05/12/2022---$-0.22---
03/18/2022---$-0.28---
11/15/2021Before Market$-1-244.83%
08/11/2021Before Market$-1.35---
05/17/2021Before Market$-1.05---
03/17/2021Before Market$-0.90---
11/16/2020After Market$-1.24-12,300.00%
09/29/2020Before Market$-1.15-5,650.00%
04/30/2020After Market$-0.02---
12/17/2019Before Market$-0.2245.00%
06/26/2019After Market$-0.20-25.00%
03/27/2019Before Market$-0.35-45.83%
12/11/2018Before Market$-0.65-109.68%
09/20/2018---$0.43---
06/05/2018Before Market$-0.5230.67%
12/06/2017Before Market$-0.2065.52%
08/31/2017Before Market$1.10214.29%
06/14/2017After Market$-0.1043.53%
03/29/2017---$-0.10---
12/15/2016After Market$-0.45-114.95%
09/08/2016Before Market$-0.650.00%
05/10/2016After Market$-0.5536.05%
12/17/2015After Market$-0.59---
08/27/2015Before Market$-0.52---
05/06/2015After Market$-0.11---

More About Summit Therapeutics PLC

Country
USA
Full Time Employees
159

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics PLC Earnings” Can Refer to the Summit Therapeutics PLC Earnings Date

Some people say “Summit Therapeutics PLC earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Summit Therapeutics PLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Summit Therapeutics PLC Stock on the Earnings Date

If you own Summit Therapeutics PLC stock (SMMT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Summit Therapeutics PLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Summit Therapeutics PLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Summit Therapeutics PLC Options on the Earnings Date

If you own Summit Therapeutics PLC options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Summit Therapeutics PLC options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Summit Therapeutics PLC options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Summit Therapeutics PLC. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Summit Therapeutics PLC options often go down. This is sometimes referred to as volatility crush.

Learning More Summit Therapeutics PLC Earnings

You can contact us any time if you would like to ask questions about Summit Therapeutics PLC earnings or anything else related to the stock market.